MOONLAKE IMMUNOTHERAPEUTICS
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-611.1K | $-611.1K | — | — |
| FY2022 | $-55.9M | $-55.9M | $16.0K | $9.7M |
| FY2023 | $-42.8M | $-43.1M | $284.0K | $7.1M |
| FY2024 | $-116.6M | $-117.1M | $520.0K | $7.3M |
| FY2025 | $-196.0M | $-196.0M | $35.0K | $12.9M |